Exact Mass: 657.2789930000001
Exact Mass Matches: 657.2789930000001
Found 45 metabolites which its exact mass value is equals to given mass value 657.2789930000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
3beta,5alpha,7beta,15beta-tetraacetoxy-9alpha-nicotinoyloxy-11alpha,12beta-epoxyjatropha-6(17)-en-14-one|kansuinin G
2beta-acetoxy-1alpha,6beta-dibenzoyloxy-4beta-hydroxy-9beta-nicotinoyloxy-dihydro-beta-agarofuran|salaterpene D
cyclo(glycyl-glycyl-L-prolyl-L-tryptophan-L-tryptopyl-L-tyrosyl-L-prolyl)|diandrine C and D
(1S,4S,5S,6R,7R,8R,9S,10S)-8-acetoxy-1,9-dibenzoyloxy-4-hydroxy-6-nicotynoyloxy-dihydro-beta-agarofuran
N-[9-[(2R,4S,5R)-4-[bis(4-methoxyphenyl)-phenylmethoxy]-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]benzamide
C38H35N5O6 (657.2587209999999)
N-ALPHA-CBZ-ARG-ARG 7-AMIDO-4-METHYLCOUMARIN HYDROCHLORIDE
C30H40ClN9O6 (657.2789930000001)
Z-Arg-Arg-AMC hydrochloride is a selective substrate of cathepsin B[1].
T 98475
Imipenem-Cilastatin sodium hydrate
C28H43N5O9S2 (657.2502068000001)
N6-Benzoyl-5-O-(4,4-diMethoxytrityl)-2-deoxyadenosine
C38H35N5O6 (657.2587209999999)
N6-Benzoyl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyadenosine can be used as an intermediate.
4-[4-[[5-Chloro-4-[[2-[(propan-2-yl)sulfonyl]phenyl]amino]pyrimidin-2-yl]amino]-5-isopropoxy-2-methylphenyl]piperidine-1-carboxylic acid tert-butyl ester
Carphenazine dimaleate
C32H39N3O10S (657.2356034000001)
C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
5-aminopentyl beta-D-glucopyranosyl-(1->3)-2,4-di-O-acetyl-6-deoxy-alpha-L-talopyranosyl-(1->3)-beta-D-glucopyranoside
C27H47NO17 (657.2843852000001)
alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group
An N-acetyl-D-galactosaminyl group in which a sialic acid residue (Neu5Ac) is linked alpha(2->3) to a galactose residue which is in turn linked beta(1->3) to the D-GalNAc group which has alpha-configuration at its anomeric centre.
5,8,17,20-tetrahydroxy-3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione
(7z,9r,10r,11r,12s,13s,14s,15r,16s,17s,18e,20z)-2,4,9,10,12,14,16,22-octahydroxy-21-(hydroxymethyl)-3,7,11,13,15,17-hexamethyl-23-azatricyclo[22.3.1.0⁵,²⁷]octacosa-1(27),2,4,7,18,20,22,24-octaene-6,26,28-trione
2,8,14-trihydroxy-3,9-bis[(4-hydroxyphenyl)methyl]-4,10,12-trimethyl-6-(2-methylpropyl)-3,6,9,12-tetrahydro-1,4,7,10,13-benzopentazacyclohexadecine-5,11-dione
C36H43N5O7 (657.3162328000001)
(3r,6r,9r,21r)-5,8,17,20-tetrahydroxy-3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione
2,4,9,10,12,14,16,22-octahydroxy-21-(hydroxymethyl)-3,7,11,13,15,17-hexamethyl-23-azatricyclo[22.3.1.0⁵,²⁷]octacosa-1,3,5(27),7,18,20,22,24-octaene-6,26,28-trione
(1r,3r,4r,6r,8r,10r,12r,13r,14s,15s)-1,10,12,14-tetrakis(acetyloxy)-3,7,7,15-tetramethyl-11-methylidene-2-oxo-5-oxatricyclo[11.3.0.0⁴,⁶]hexadecan-8-yl pyridine-3-carboxylate
1,10,12,14-tetrakis(acetyloxy)-3,7,7,15-tetramethyl-11-methylidene-2-oxo-5-oxatricyclo[11.3.0.0⁴,⁶]hexadecan-8-yl pyridine-3-carboxylate
(8s,10s)-8-acetyl-10-{[(2r,4s,5s,6s)-4-amino-5-{3-hydroxy-1-[(1-hydroxypropan-2-yl)oxy]butoxy}-6-methyloxan-2-yl]oxy}-8,11-dihydroxy-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione
(3s,6s,9s,12s)-2,8,14-trihydroxy-3,9-bis[(4-hydroxyphenyl)methyl]-4,10,12-trimethyl-6-(2-methylpropyl)-3,6,9,12-tetrahydro-1,4,7,10,13-benzopentazacyclohexadecine-5,11-dione
C36H43N5O7 (657.3162328000001)